InspireMD (NSPR) Misses Q1 EPS by 4c

InspireMD (NASDAQ: NSPR) reported Q1 EPS of ($0.21), $0.04 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $1.51 million versus the consensus estimate of $2 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Integra Resources (ITRG) Tops Q2 EPS by 6c
• Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c